Jazz Pharmaceuticals plc Business Combination, Consideration Transferred
Jazz Pharmaceuticals plc (JAZZ) reported Business Combination, Consideration Transferred of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-24.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2015-02-24
- Jazz Pharmaceuticals plc business combination, consideration transferred for fiscal 2014 was $0.00.
- Jazz Pharmaceuticals plc business combination, consideration transferred for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- Jazz Pharmaceuticals plc business combination, consideration transferred for fiscal 2012 was $576.46M.
- Jazz Pharmaceuticals plc business combination, consideration transferred for fiscal 2011 was $0.00.
| Period end | Business Combination, Consideration Transferred 12 month |
|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-02-24 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-24 |
| 2012-12-31 | $576.46M 10-K · filed 2015-02-24 |
| 2011-12-31 | $0.00 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |